Plastic syringe TopPac that meets CCI (Container Closure Integrity) at -80℃.
SCHOTT's plastic syringe "TopPac" is used as a pre-filled syringe by many pharmaceutical companies around the world due to its excellent performance and quality. Recent studies have shown that even after repeated freeze/thaw cycles and storage or transportation at -80°C, container closure integrity (CCI) is maintained. It is expected to serve as a next-generation pharmaceutical packaging material that can replace glass containers for mRNA pharmaceuticals, which require ultra-low temperature storage, when considering the lifecycle management of pharmaceutical containers. Additionally, by applying a special silicone coating, particle generation can be minimized. It also excels in oxygen barrier properties. The product is delivered sterilized. Sizes range from 1ml Long to 50ml, and shapes can be customized.
Inquire About This Product
basic information
COC (Cyclic Olefin Copolymer) -80℃ CCI (Container Closure Integrity) Container Integrity mRNA Pharmaceuticals Sterilized
Price range
Delivery Time
Applications/Examples of results
Packaging for hyaluronic acid for cosmetic surgery Packaging for immunoglobulin Packaging for neuromuscular relaxants Packaging for mRNA drugs
Line up（8）
| Model number | overview |
|---|---|
| TopPac 1ml Long | Standard product |
| TopPac 1ml | Standard product |
| TopPac 2.25ml | Standard product |
| TopPac 3ml | Standard product |
| TopPac 5ml | Standard product |
| TopPac 10ml | Standard product |
| TopPac 20ml | Standard product |
| TopPac 50ml | Standard product |
Company information
Shot is an international technology group leading in the fields of specialty glass and glass-ceramics. With over 140 years of outstanding research and development, as well as a wealth of materials and expertise, we provide a wide range of high-quality products and intelligent solutions that contribute to our customers' success. Shot brings innovation to many industries, including home appliances, pharmaceuticals, electronics, optics, automotive, and aerospace. Shot aims to play a significant role in the lives of everyone. The core company of the group, Shot AG, is a wholly-owned subsidiary of the Carl Zeiss Foundation. Shot Japan Co., Ltd. was established in 1966 as the first sales subsidiary of the Shot Group in Asia. In February 2018, we integrated the Tokyo Sales Department, which sells optical glass, crystallized glass, thin glass, heat-resistant glass, glass tubes, optical fibers, and primary containers for pharmaceuticals, with the Mizuguchi plant, which develops and sells electronic packaging, to provide Shot's technology and products under a new structure.
